Publications by authors named "Elisa Testino"

Claim this Profile
C
Carbon Footprint Impact, of Monoclonal Antibodies for Severe Asthma, Administered in Italy.
Diego Bagnasco, Laura Pini, Benedetta Bondi, Carola Montagnino, Elisa Testino

Biomedicines· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Background therapy in severe asthma on monoclonal antibody treatment in real life.
Filippo F Cosini, Diego Bagnasco, Fulvio Braido, G Walter Canonica, Giovanni Passalacqua, Elisa Testino

Respir Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders.
Diego Bagnasco, Stefania Nicola, Elisa Testino, Luisa Brussino, Laura Pini

Biomedicines· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific Therapy for T2 Asthma.
Diego Bagnasco, Elisa Testino, Stefania Nicola, Laura Melissari, Maria Russo

J Pers Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe asthma: One disease and multiple definitions.
Diego Bagnasco, Pierluigi Paggiaro, Manuela Latorre, Chiara Folli, Elisa Testino

World Allergy Organ J· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of being not significant: Blood eosinophils and clinical responses do not correlate in severe asthma patients treated with mepolizumab in real life.
Diego Bagnasco, Alessandro Massolo, Marco Bonavia, Luisa Brussino, Caterina Bucca, Elisa Testino

Allergy· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One year of mepolizumab. Efficacy and safety in real-life in Italy.
Diego Bagnasco, Marco Caminati, Francesco Menzella, Manlio Milanese, Giovanni Rolla, Elisa Testino

Pulm Pharmacol Ther· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-IL-5 and IL-5Ra: Efficacy and Safety of New Therapeutic Strategies in Severe Uncontrolled Asthma.
Diego Bagnasco, Marco Caminati, Matteo Ferrando, Teresita Aloè, Elisa Testino

Biomed Res Int· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of monoclonal antibodies for asthma treatment.
Diego Bagnasco, Enrico Heffler, Elisa Testino, Giovanni Passalacqua, Giorgio Walter Canonica

Expert Opin Drug Metab Toxicol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis